Global Animal Growth Promoters And Performance Enhancers Market Size, Share Analysis Report By Animal (Poultry, Porcine, Livestock, Equine, Others), By Product (Hormonal Growth Promoters, Antibiotic Growth Promoters, Feed Enzyme Growth Promoters, Organic acid Growth Promoters, Others, By Distribution Channel, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) , By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview

The Global Animal Growth Promoters And Performance Enhancers Market size is expected to be worth around USD 31.1 Billion by 2035, from USD 17.1 Billion in 2025, growing at a CAGR of 6.1% during the forecast period from 2026 to 2035. In 2025, Europe held a dominant market position, capturing more than a 37.4% share, holding USD 0.7 Billion revenue.

The Animal Growth Promoters and Performance Enhancers industry is moving from a volume-led feed-additive model toward a precision productivity model shaped by animal health, feed efficiency, residue compliance, and antimicrobial stewardship. In 2025, the commercial backdrop remains favorable because global meat production is forecast to reach 384 million tonnes, up 1.4% year on year, with poultry alone projected at 154.4 million tonnes, pig meat at 126.3 million tonnes, and bovine meat at 78.0 million tonnes. Global per-caput meat consumption is also forecast at 46.4 kg/year. 

The industrial scenario is increasingly regulation-led. WOAH’s 2025 antimicrobial-use report shows 157 reports were submitted in the ninth round, equal to 81% of reporting entities, while 34 out of 157 reporters, or 22%, still indicated antimicrobial use for growth promotion in 2022. By contrast, 112 out of 157, or 71%, reported no such use.

The European Commission states that Regulation (EU) 2019/6 entered into application on 28 January 2022 and is central to the EU objective of reducing antimicrobial sales for farmed animals and aquaculture by 50% by 2030. In the United States, FDA’s GFI #263 was successfully implemented in June 2023, moving the remaining over-the-counter medically important antimicrobials to prescription status. Together, these measures are reorienting industry demand toward non-antibiotic performance technologies with stronger compliance value.

Demand-side drivers remain strong. Industry data from Alltech’s 2025 Agri-Food Outlook shows that global feed production increased by 1.2% in 2024 to 1.396 billion metric tons, based on data from more than 27,000 feed mills in 142 countries. That scale matters because performance enhancers are typically embedded in feed strategies, making feed output a practical proxy for additive demand. On the risk-management side, WOAH reported in 2025 that its antimicrobial-use analysis covered 71% of the world’s animal biomass and found global antimicrobial use in animals fell from 102 mg to 97 mg per kg of animal biomass between 2020 and 2022, a 5% decline.

Bayer Animal Health is no longer a standalone operating competitor, because Bayer completed the sale of that business to Elanco in August 2020, with the transaction valued at US$6.89 billion by Elanco and US$7.6 billion at announcement. That matters strategically because legacy Bayer animal-health assets now compete through Elanco’s platform, not Bayer’s current reporting structure.

Key Takeaways

• Animal Growth Promoters And Performance Enhancers Market size is expected to be worth around USD 31.1 Billion by 2035, from USD 17.1 Billion in 2025, growing at a CAGR of 6.1%.
• Poultry held a dominant market position, capturing more than a 42.7% share.
• Feed Enzyme Growth Promoters held a dominant market position, capturing more than a 34.6% share.
• Retail Pharmacy held a dominant market position, capturing more than a 46.3% share.
• North America held a dominant position in the Animal Growth Promoters & Performance Enhancers Market, accounting for 34.8% of the global market and reaching nearly USD 5.9 billion.

By Animal Analysis

Poultry dominates with 42.7% share, supported by strong demand from commercial farming and faster production cycles.

In 2025, Poultry held a dominant market position, capturing more than a 42.7% share in the Animal Growth Promoters & Performance Enhancers Market by animal segment. This leading position was mainly supported by the large-scale expansion of poultry farming across both developed and emerging regions, where producers continue to focus on improving feed efficiency, faster weight gain, and better flock health. The poultry segment remains highly performance-driven, with farmers prioritizing solutions that help improve growth rates while maintaining consistent meat and egg output.

By Product Analysis

Feed enzyme growth promoters lead with 34.6% share, driven by better nutrient absorption and improved feed efficiency.

In 2025, Feed Enzyme Growth Promoters held a dominant market position, capturing more than a 34.6% share in the Animal Growth Promoters & Performance Enhancers Market by product segment. This strong position was largely supported by the growing focus on improving feed utilization and reducing overall production costs in livestock farming. Feed enzymes are widely used because they help animals digest nutrients more effectively, allowing producers to get better growth performance from the same quantity of feed. This is especially important as feed remains one of the largest expenses in animal production.

By Distribution Channel Analysis

Retail pharmacy leads with 46.3% share, helped by easy product access and strong trust among livestock buyers.

In 2025, Retail Pharmacy held a dominant market position, capturing more than a 46.3% share in the Animal Growth Promoters & Performance Enhancers Market by distribution channel segment. This leading share was mainly supported by the wide availability of animal health and performance products through established retail pharmacy networks, especially in regions with a strong base of commercial farms and independent livestock owners. Farmers and animal producers continue to prefer retail pharmacies because they offer convenient access to trusted products, quick purchasing, and professional guidance on usage.

Key Market Segments

By Animal

• Poultry
• Porcine
• Livestock
• Equine
• Others

By Product

• Hormonal Growth Promoters
• Antibiotic Growth Promoters
• Feed Enzyme Growth Promoters
• Organic acid Growth Promoters
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Emerging Trends

Shift Toward Natural and Gut-Health-Based Feed Solutions is the Latest Industry Trend

One of the most visible latest trends in the Animal Growth Promoters & Performance Enhancers Market is the fast shift toward natural feed additives, especially probiotics, prebiotics, phytogenics, and enzyme-based gut health solutions. This trend is becoming stronger as livestock producers look for residue-free growth support that also aligns with stricter antibiotic regulations. A strong numerical indicator behind this trend comes from FAO, which states that 34% of the global food protein supply comes from livestock, showing how important efficient animal production has become at the global level.

Precision Feeding and Sustainable Feed Technologies are Gaining Fast Adoption

Another major latest trend is the growing use of precision feeding and sustainable feed technologies across commercial livestock farming. Producers are increasingly using data-led nutrition planning, targeted amino acid balancing, and species-specific feed enhancer combinations to improve performance outcomes. This trend is strongly supported by FAO’s livestock framework, which notes that animals consume about 6 billion tonnes of feed dry matter annually, while 86% of global livestock feed intake comes from materials not edible by humans.

Drivers

Rising Global Animal Protein Consumption is Accelerating the Need for Better Growth Efficiency

One of the biggest drivers for the Animal Growth Promoters & Performance Enhancers Market is the steady rise in global demand for animal protein, especially poultry, eggs, dairy, and meat. As consumption continues to increase, livestock producers are under constant pressure to improve feed conversion, shorten growth cycles, and maintain animal health without increasing production costs too sharply.

According to the OECD-FAO Agricultural Outlook 2025–2034, global consumption of animal-source foods is expected to keep expanding over the next decade, with emerging economies leading this growth. The report highlights that poultry remains one of the fastest-growing protein categories because of its affordability and shorter production cycle.

Government Food Security and Livestock Productivity Programs are Strengthening Market Demand

Another major growth driver is the strong push from governments and global food organizations toward livestock productivity and food security improvement. Many countries are actively supporting better animal nutrition, disease control, and scientific feeding practices to strengthen domestic meat and dairy supply chains.

FAO continues to work with governments worldwide on sustainable animal production systems, focusing on improved feed efficiency, livestock resilience, and better farm productivity. These initiatives are especially important as the FAO 2025 food security update noted that 28% of the global population faced moderate or severe food insecurity in 2024, increasing the urgency to improve agricultural and livestock output.

Restraints

Strict Antibiotic Regulations and AMR Controls are Limiting Traditional Growth Promoter Use

One of the biggest restraining factors for the Animal Growth Promoters & Performance Enhancers Market is the tightening regulation around antibiotic-based growth promoters. Across major livestock-producing regions, governments and food safety bodies are placing stronger restrictions on the routine use of antibiotics in feed because of antimicrobial resistance concerns.

The Food and Agriculture Organization (FAO) clearly states that one of the most direct ways to reduce antimicrobial resistance is to ban or minimize antibiotics used for growth promotion in animal production. The European Union has already enforced a complete ban on antibiotic growth promoters since 2006, and this continues to influence global feed practices as many countries align their standards with EU and Codex guidance.

Government Bans on Critical Veterinary Drugs are Increasing Compliance Burden

Another strong restraint comes from country-level bans on specific antimicrobial molecules that were once commonly used in feed and animal production systems. For example, India strengthened its antimicrobial resistance response through the National Action Plan on AMR 2.0 (2025–2029) and has expanded controls on veterinary antimicrobial use.

In a major regulatory move, India reported a ban on 37 antimicrobial drugs in 2025, including 18 antibiotics, across livestock production systems. This type of policy action creates immediate pressure on feed manufacturers, animal nutrition companies, and farmers to replace existing formulations with approved alternatives.

Opportunity

Natural Feed Additives and Precision Nutrition are Opening the Biggest Growth Opportunity

One of the strongest growth opportunities in the Animal Growth Promoters & Performance Enhancers Market is the rapid shift toward natural feed additives and precision nutrition solutions. As antibiotic restrictions continue globally, livestock producers are actively moving toward enzymes, probiotics, phytogenics, and gut-health enhancers that can improve growth without residue concerns.

This opportunity is becoming larger because global demand for animal-source foods is still rising. The OECD-FAO Agricultural Outlook 2025–2034 shows that global per capita calorie intake from livestock and fish products is expected to rise by 6% over the next decade, while lower-middle-income countries may see 24% growth, nearly four times the global average.

Emerging Economies and Government Livestock Modernization Programs Offer High-Potential Expansion

A second major growth opportunity lies in emerging economies where governments are investing in livestock modernization, feed quality, and food security. FAO notes that livestock already contributes 20% of agricultural output in developing countries and supports the livelihoods of at least 1.3 billion people worldwide, showing the scale of opportunity linked to productivity improvement.

Government-backed livestock master plans, animal nutrition programs, and feed safety initiatives are especially creating opportunities for enzyme blends, probiotics, and sustainable feed technologies. FAO’s livestock development framework also highlights the use of novel feed sources, better feed safety, and improved feeding systems as priority areas for long-term sector growth.

Regional Insights

North America dominates with 34.8% share, reaching USD 5.9 Bn on the back of advanced livestock production and high feed efficiency adoption

In 2025, North America held a dominant position in the Animal Growth Promoters & Performance Enhancers Market, accounting for 34.8% of the global market and reaching nearly USD 5.9 billion. This leadership is strongly supported by the region’s highly commercialized livestock and poultry industry, especially across the United States and Canada, where large-scale broiler, swine, and dairy operations continue to prioritize feed efficiency, faster weight gain, and animal wellness.

The United States remains the core revenue contributor due to its strong poultry and red meat production base. According to the USDA livestock and poultry outlook, total U.S. red meat and poultry production is projected to reach 108.4 billion pounds in 2025, reflecting sustained high-volume animal farming demand.

The region’s dominance is also linked to the widespread adoption of enzyme-based growth promoters, probiotics, amino acids, and gut-health solutions that help improve feed conversion ratios in intensive farming systems. Commercial poultry remains a major support pillar, with USDA projections showing broiler exports of 6.97 billion pounds in 2025, highlighting the scale of production efficiency requirements across North America.

Key Regions and Countries Insights

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of MEA

Key Players Analysis

Biomin Holding GmbH remains a key name in feed additives and performance nutrition, particularly in enzymes, probiotics, mycotoxin risk management, and gut health solutions. The company’s strength is closely reflected through dsm-firmenich’s Animal Nutrition & Health business, which generated approximately €3.5 billion in net sales in 2025. This numerical scale highlights the strong commercial importance of feed efficiency and science-based nutrition solutions in livestock production.

Boehringer Ingelheim remains one of the strongest global players in animal health, supported by vaccines, parasiticides, therapeutics, and preventive livestock solutions. In 2025, its Animal Health business reported €4.9 billion in sales, showing the company’s strong scale in both livestock and companion animal markets. This financial size reflects deep penetration across poultry, swine, cattle, and pet health categories, where disease prevention and productivity improvement remain central.

Top Key Players Outlook

• Bayer Animal Health
• Biomin Holding GmbH
• Bioniche Animal Health
• Boehringer Ingelheim
• Bupo Animal Health
• Cargill Inc.
• DSM
• Elanco Animal Health Incorporated
• Merck Animal Health
• Zoetis Inc.

Recent Industry Developments

In 2025, Bayer Animal Health’s role in the Animal Growth Promoters & Performance Enhancers sector continued to be reflected through its strong legacy portfolio in livestock health, feed-support medicines, anti-infectives, and productivity-focused solutions that are now integrated into Elanco’s farm animal business. The company’s strategic importance in this space is clearly visible from the USD 7.6 billion acquisition value of Bayer Animal Health by Elanco, a move that significantly expanded livestock solutions across poultry, cattle, and swine production systems.

Biomin’s role in this sector is still important because its solutions help reduce feed risks, protect gut health, and support better livestock output, but for 2025 and 2026 company data in numerical format, the practical read is: 2020 acquisition value €980m; 2024 ANH revenue >€3.3bn; 2025 ANH sales ~€3.5bn; 2025 ANH Adjusted EBITDA ~€0.5bn; workforce >6,000; footprint 60+ countries.

Report Scope